Investors pour $250 mln into new Africa pharmaceuticals company
A group of three founding investors is pouring $250 million into a new company to acquire and create biopharmaceuticals businesses
Read moreA group of three founding investors is pouring $250 million into a new company to acquire and create biopharmaceuticals businesses
Read more